Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality

OBJECTIVE: Metformin has had a 'black box' contraindication in diabetic patients with heart failure (HF), but many believe it to be the treatment of choice in this setting. Therefore, we attempted to conduct a pilot study to evaluate the feasibility of undertaking a large randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Eurich, Dean T, Tsuyuki, Ross T, Majumdar, Sumit R, McAlister, Finlay A, Lewanczuk, Richard, Shibata, Marcelo C, Johnson, Jeffrey A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644685/
https://www.ncbi.nlm.nih.gov/pubmed/19203392
http://dx.doi.org/10.1186/1745-6215-10-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644685/
https://www.ncbi.nlm.nih.gov/pubmed/19203392
http://dx.doi.org/10.1186/1745-6215-10-12

Ejemplares similares